Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis

Clinical trial NCT01209208 · COMPLETED

Trial details

NCT number: NCT01209208
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphocytic Colitis

Start date: 2010-05-01
Primary completion: 2017-06-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.